Information:
Error:
ID
22903
Description
Randomized, Open Label Multi-Center Study Comparing Cabazitaxel at 20 mg/m² and at 25 mg/m² Every 3 Weeks in Combination With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen Other drug name: Jevtana® Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT01308580 Sponsor: Sanofi
Link
https://clinicaltrials.gov/ct2/show/NCT01308580
Keywords
Versions (1)
- 6/15/17 6/15/17 -
Uploaded on
June 15, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CRFs Cabazitaxel Prostate Cancer DRKS00006520 NCT01308580 Death
CRFs Cabazitaxel Prostate Cancer NCT01308580 Death
- StudyEvent: ODM
Similar models
CRFs Cabazitaxel Prostate Cancer NCT01308580 Death
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date of Death
Item
Date of Death
date
C1148348 (UMLS CUI [1])
CL Item
Disease Progression (Disease Progression)
CL Item
Adverse Event (Adverse Event)
CL Item
Other Reason (Other Reason)
Cause of Death Specification
Item
Other, Specify:
text
C2348235 (UMLS CUI [1,1])
C0007465 (UMLS CUI [1,2])
C0007465 (UMLS CUI [1,2])
No comments